CD274 and cancer: PD-1/PD-L1 blockade has been revolutionary in cancer immunotherapy, and it has been used in the treatment of numerous malignancies, including melanoma12, hepatocellular carcinoma13, non-small cell lung cancer14,15, breast cancer16, as well as Hodgkin’s lymphoma17.